GT Biopharma Inc (GTBP) — Cash Flow-to-Debt Ratio
GT Biopharma Inc (GTBP) has a Cash Flow-to-Debt Ratio of -1.73x as of December 2025, meaning its operating cash flow of $-4.02 Million could theoretically repay -2% of its total liabilities ($2.32 Million) in one year. See GTBP free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GT Biopharma Inc Cash Flow-to-Debt Ratio (1985–2025)
Historical debt coverage capacity for GT Biopharma Inc across 41 annual periods. Also explore GT Biopharma Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for GT Biopharma Inc (1985–2025)
Year-by-year debt coverage analysis for GT Biopharma Inc. For market capitalisation and broader financial context, see GTBP stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.57x | $-12.91 Million | $2.32 Million | ▼ -154.7% |
| 2024 | -2.19x | $-12.90 Million | $5.90 Million | ▼ -63.8% |
| 2023 | -1.33x | $-8.85 Million | $6.63 Million | ▲ +56.1% |
| 2022 | -3.04x | $-15.22 Million | $5.00 Million | ▼ -100.0% |
| 2021 | -1.52x | $-15.61 Million | $10.26 Million | ▼ -635.1% |
| 2020 | -0.21x | $-7.26 Million | $35.09 Million | ▼ -11.4% |
| 2019 | -0.19x | $-3.66 Million | $19.71 Million | ▲ +75.6% |
| 2018 | -0.76x | $-10.68 Million | $14.03 Million | ▲ +62.5% |
| 2017 | -2.03x | $-5.43 Million | $2.68 Million | ▼ -1890.0% |
| 2016 | -0.10x | $-1.93 Million | $18.95 Million | ▼ -10.7% |
| 2015 | -0.09x | $-4.66 Million | $50.62 Million | ▼ -60.2% |
| 2014 | -0.06x | $-1.75 Million | $30.46 Million | ▲ +15.8% |
| 2013 | -0.07x | $-442.00K | $6.48 Million | ▲ +54.7% |
| 2012 | -0.15x | $-987.00K | $6.56 Million | ▲ +18.3% |
| 2011 | -0.18x | $-963.00K | $5.23 Million | ▲ +32.2% |
| 2010 | -0.27x | $-1.53 Million | $5.65 Million | ▼ -105.9% |
| 2009 | -0.13x | $-937.00K | $7.11 Million | ▼ -233.1% |
| 2008 | -0.04x | $-169.00K | $4.27 Million | ▲ +52.7% |
| 2007 | -0.08x | $-270.00K | $3.23 Million | ▲ +2.7% |
| 2006 | -0.09x | $-671.00K | $7.80 Million | ▲ +82.5% |
| 2005 | -0.49x | $-2.09 Million | $4.27 Million | ▼ -26.1% |
| 2004 | -0.39x | $-1.04 Million | $2.68 Million | ▼ -85.6% |
| 2003 | -0.21x | $-229.00K | $1.09 Million | ▲ +84.1% |
| 2002 | -1.31x | $-1.01 Million | $767.00K | ▼ -9.6% |
| 2001 | -1.20x | $-1.43 Million | $1.19 Million | ▲ +52.1% |
| 2000 | -2.50x | $-3.89 Million | $1.55 Million | ▼ -152.3% |
| 1999 | -0.99x | $-2.48 Million | $2.50 Million | ▲ +23.6% |
| 1998 | -1.30x | $-5.20 Million | $4.00 Million | ▼ -57.1% |
| 1997 | -0.83x | $-4.80 Million | $5.80 Million | ▲ +32.6% |
| 1996 | -1.23x | $-4.30 Million | $3.50 Million | ▼ -29.8% |
| 1995 | -0.95x | $-5.30 Million | $5.60 Million | ▼ -1164.7% |
| 1994 | 0.09x | $400.00K | $4.50 Million | ▲ +101.7% |
| 1993 | -5.33x | $-1.60 Million | $300.00K | ▼ -540.0% |
| 1992 | -0.83x | $-500.00K | $600.00K | ▲ +16.7% |
| 1991 | -1.00x | $-200.00K | $200.00K | ▼ -122.2% |
| 1990 | 4.50x | $900.00K | $200.00K | ▲ +221.4% |
| 1989 | 1.40x | $700.00K | $500.00K | ▲ +320.0% |
| 1988 | 0.33x | $100.00K | $300.00K | ▲ +33.3% |
| 1987 | 0.25x | $50.00K | $200.00K | ▲ +131.3% |
| 1986 | -0.80x | $-400.00K | $500.00K | ▲ +73.3% |
| 1985 | -3.00x | $-300.00K | $100.00K | — |